rolipram has been researched along with Eosinophilia, Pulmonary in 5 studies
| Excerpt | Relevance | Reference |
|---|---|---|
| "This study investigates the role of adrenal-derived catecholamines and corticosterone on the inhibition by rolipram, a phosphodiesterase (PDE)-4 inhibitor, of pulmonary eosinophilia and airway hyperresponsiveness (AHR) in allergic mice." | 7.70 | Inhibition of pulmonary eosinophilia and airway hyperresponsiveness in allergic mice by rolipram: involvement of endogenously released corticosterone and catecholamines. ( Chapman, RW; Crawley, Y; Kreutner, W; Kung, TT; Luo, B; Young, S, 2000) |
| "This study investigates the role of adrenal-derived catecholamines and corticosterone on the inhibition by rolipram, a phosphodiesterase (PDE)-4 inhibitor, of pulmonary eosinophilia and airway hyperresponsiveness (AHR) in allergic mice." | 3.70 | Inhibition of pulmonary eosinophilia and airway hyperresponsiveness in allergic mice by rolipram: involvement of endogenously released corticosterone and catecholamines. ( Chapman, RW; Crawley, Y; Kreutner, W; Kung, TT; Luo, B; Young, S, 2000) |
| "Pretreatment with rolipram (30 mumol/kg) and Org 20421 (30 mumol/kg) abolished the eosinophilia and neutrophilia evoked by ovalbumin." | 1.29 | Inhibition of allergen-induced lung eosinophilia by type-III and combined type III- and IV-selective phosphodiesterase inhibitors in brown-Norway rats. ( Barnes, PJ; Chung, KF; Elwood, W; Giembycz, MA; Sun, J, 1995) |
| Timeframe | Studies, this research(%) | All Research% |
|---|---|---|
| pre-1990 | 0 (0.00) | 18.7374 |
| 1990's | 2 (40.00) | 18.2507 |
| 2000's | 2 (40.00) | 29.6817 |
| 2010's | 1 (20.00) | 24.3611 |
| 2020's | 0 (0.00) | 2.80 |
| Authors | Studies |
|---|---|
| Pruniaux, MP | 1 |
| Lagente, V | 1 |
| Ouaged, M | 1 |
| Bertin, B | 1 |
| Moreau, F | 1 |
| Julien-Larose, C | 1 |
| Rocher, MN | 1 |
| Leportier, C | 1 |
| Martin, B | 1 |
| Bouget, A | 1 |
| Dubuit, JP | 1 |
| Burnouf, C | 1 |
| Doherty, AM | 1 |
| Bertrand, CP | 1 |
| Elwood, W | 1 |
| Sun, J | 1 |
| Barnes, PJ | 1 |
| Giembycz, MA | 1 |
| Chung, KF | 1 |
| Underwood, DC | 1 |
| Kotzer, CJ | 1 |
| Bochnowicz, S | 1 |
| Osborn, RR | 1 |
| Luttmann, MA | 1 |
| Hay, DW | 1 |
| Torphy, TJ | 1 |
| Kung, TT | 1 |
| Crawley, Y | 1 |
| Luo, B | 1 |
| Young, S | 1 |
| Kreutner, W | 1 |
| Chapman, RW | 1 |
| Ikemura, T | 1 |
| Schwarze, J | 1 |
| Makela, M | 1 |
| Kanehiro, A | 1 |
| Joetham, A | 1 |
| Ohmori, K | 1 |
| Gelfand, EW | 1 |
5 other studies available for rolipram and Eosinophilia, Pulmonary
| Article | Year |
|---|---|
Relationship between phosphodiesterase type 4 inhibition and anti-inflammatory activity of CI-1044 in rat airways.
Topics: Administration, Oral; Animals; Azepines; Carboxylic Acids; Cyclohexanecarboxylic Acids; Disease Mode | 2010 |
Inhibition of allergen-induced lung eosinophilia by type-III and combined type III- and IV-selective phosphodiesterase inhibitors in brown-Norway rats.
Topics: Administration, Inhalation; Aerosols; Analysis of Variance; Animals; Anti-Inflammatory Agents, Non-S | 1995 |
Comparison of phosphodiesterase III, IV and dual III/IV inhibitors on bronchospasm and pulmonary eosinophil influx in guinea pigs.
Topics: Animals; Antigens; Bronchial Spasm; Bronchoalveolar Lavage Fluid; Bronchoconstriction; Drug Synergis | 1994 |
Inhibition of pulmonary eosinophilia and airway hyperresponsiveness in allergic mice by rolipram: involvement of endogenously released corticosterone and catecholamines.
Topics: Animals; Antihypertensive Agents; Bronchial Hyperreactivity; Bronchoalveolar Lavage; Catecholamines; | 2000 |
Type 4 phosphodiesterase inhibitors attenuate respiratory syncytial virus-induced airway hyper-responsiveness and lung eosinophilia.
Topics: 3',5'-Cyclic-AMP Phosphodiesterases; 4-(3-Butoxy-4-methoxybenzyl)-2-imidazolidinone; Animals; Bronch | 2000 |